InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Novel Ingredients in Infant Formula Market”-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034.”
Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2977
In infant nutrition, “novel ingredients” refer to bioactive compounds that extend beyond conventional macronutrients and micronutrients—such as proteins, fats, carbohydrates, vitamins, and minerals—with the objective of more closely replicating the composition and functional benefits of human breast milk. One prominent example is Milk Fat Globule Membrane (MFGM), a complex trilayer structure that envelops fat globules in breast milk.
MFGM is rich in bioactive constituents, including phospholipids, cholesterol, and specialized proteins such as lactoferrin and osteopontin, which are associated with enhanced cognitive development, neurological function, and immune support in infants. Advances in extraction and stabilization technologies have enabled the successful incorporation of MFGM into commercially available infant formula products, improving their functional profile.
In parallel, the integration of novel prebiotics—non-digestible dietary fibers that selectively stimulate the growth of beneficial gut microbiota—is gaining increased attention. Commonly utilized compounds, including galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), are widely recognized for their role in supporting digestive health and overall infant well-being.
Consumer preferences are increasingly shifting toward infant formulas enriched with functional ingredients that support key areas of development, including immune health, gastrointestinal function, and cognitive performance. This trend is particularly pronounced in specialized formulations designed to address specific nutritional requirements. The growing inclusion of prebiotics, probiotics, and postbiotics reflects the industry’s emphasis on promoting a healthy gut microbiome, which is considered critical for immune system development.
Furthermore, advancements in biotechnology have enabled the development of sophisticated components such as human milk oligosaccharides (HMOs) and MFGM, which closely emulate the functional characteristics of breast milk. These innovations are significantly enhancing the nutritional value of next-generation infant formulas, positioning them as viable alternatives in situations where breastfeeding is not possible.
Read Comprehensive Report Overview: https://www.insightaceanalytic.com/report/novel-ingredients-in-infant-formula-market/2977
List of Prominent Players in the Novel Ingredients in Infant Formula Market:
- DSM
- FrieslandCampina
- Novonesis (Chr. Hansen + Novozymes)
- DuPont (IFF Nutrition)
- BASF
- AAK
- Glycosyn
- Inbiose
- Kyowa Hakko
- Nestlé
- Danone (Nutricia)
- Abbott Nutrition
- Reckitt (Mead Johnson)
- Arla Foods
- Fonterra
- Helaina
- Biomilq
- 108LABS
- Turtletree Labs
- Else Nutrition
- ByHeart
- Sprout Organic
- Conagen
- Nature’s One
- Bactolife
- Evonik
- Glycotope
Market Dynamics
Drivers:
The increasing focus on infant health and optimal nutrition is a key factor driving the adoption of advanced ingredients within the infant formula industry. Rising consumer awareness and health consciousness are contributing to greater demand for premium formulations enriched with functional components such as human milk oligosaccharides (HMOs), milk fat globule membrane (MFGM), and bioengineered proteins. These ingredients are widely associated with supporting immune system development, gastrointestinal health, and cognitive function.
In addition, the growing incidence of food allergies, digestive disorders, and metabolic conditions among infants is accelerating demand for specialized and hypoallergenic formulations. In response to these evolving needs, manufacturers are making substantial investments in research and development to introduce innovative, high-performance nutritional solutions tailored to specific health requirements.
Challenges:
Despite strong growth potential, the market faces notable barriers to the widespread adoption of novel ingredients. Stringent regulatory approval processes represent a major challenge, as they require extensive validation of safety and efficacy prior to commercialization, often resulting in prolonged timelines and increased costs. Furthermore, the development and introduction of new ingredients necessitate significant investment in research, advanced production technologies, and specialized infrastructure, creating barriers to entry for small and mid-sized companies.
Regional Trends:
The Asia-Pacific region continues to represent both the largest and fastest-growing market for infant formula, supported by relatively higher birth rates, rapid urbanization, and increasing disposable incomes. China plays a pivotal role in regional growth, driven by supportive government policies and a well-established retail ecosystem. However, shifting demographics, including declining birth rates and an aging population, are prompting domestic manufacturers to diversify into adjacent segments such as adult nutrition.
In contrast, North America is a leading market for the development and adoption of advanced infant formula ingredients, supported by robust regulatory frameworks and a strong emphasis on pediatric health. Consumers in this region demonstrate a growing preference for organic, non-GMO, and clean-label products, reflecting heightened awareness regarding product safety, quality standards, and supply chain transparency. Collectively, these regional dynamics are shaping the global adoption and integration of innovative ingredients within the infant nutrition sector.
Add our site to Google Preferred Sources for quality content: https://google.com/preferences/source?q=insightaceanalytic.com
Recent Developments:
- In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich’s HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2′-O-Fucosyllactose (2′-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
- In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
- In Sep 2023, Danone, the head of Danone’s early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers’ milk, according to Growth Asia.
Segmentation of Novel Ingredients in Infant Formula Market.
Global Novel Ingredients in Infant Formula Market – By Ingredient Type
- Human Milk Oligosaccharides (HMOs)
- Milk Fat Globule Membrane (MFGM)
- Synthetic/Bioengineered Proteins
- Next-Gen Probiotics
- Plant-Based Bioactives
- Glycomacropeptides (GMPs)
- Exosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market – By Application
- Standard Infant Formula
- Follow-On Formula
- Specialty Formula
- Growing-Up Milk
Global Novel Ingredients in Infant Formula Market – By Source
- Bioengineered
- Plant-Based
- Animal-Derived
Global Novel Ingredients in Infant Formula Market – By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Customize this Study according to your Requirements @ https://www.insightaceanalytic.com/customisation/2977
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
